People on the Move
Cobra
Contract manufacturing organisation (CMO) Cobra Biologics has appointed Daniel Smith as Chief Scientific Officer. He will be responsible for the company’s R&D across its DNA, virus, microbial and mammalian proteins.
Smith’s previous work includes four years on the UK bioprocessing team of the HealthTech & Medicines Knowledge Transfer Network (KTN), and scientific, R&D roles at Cobra.
Cobra was named last month by the French Ministry of Higher Education and Research (MESR) as a preferred provider, meaning monoclonal antibody (mAb) companies using the CMO will receive a tax break of up to 35%.